6623-2029 Screening compound: ethyl 2-[2-(2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido)-4-methylpentanamido]acetate

6623-2029 Screening compound: ethyl 2-[2-(2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido)-4-methylpentanamido]acetate
6623-2029 Screening compound: ethyl 2-[2-(2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido)-4-methylpentanamido]acetate alternative view

Chemical Structure Depiction of ChemDiv screening compound 6623-2029
ethyl 2-[2-(2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido)-4-methylpentanamido]acetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6623-2029

Molecular Formula

C24H37N3O6 (C24 H37 N3 O6)

Compound Name

ethyl 2-[2-(2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido)-4-methylpentanamido]acetate

IUPAC name

ethyl 2-[2-(2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido)-4-methylpentanamido]acetate

SMILES

CCOC(CNC(C(CC(C)C)NC(C(CC(C)C)NC(OCc1ccccc1)=O)=O)=O)=O

InChI

InChI=1S/C24H37N3O6/c1-6-32-21(28)14-25-22(29)19(12-16(2)3)26-23(30)20(13-17(4)5)27-24(31)33-15-18-10-8-7-9-11-18/h7-11,16-17,19-20H,6,12-15H2,1-5H3,(H,25,29)(H,26,30)(H,27,31)

InChI Key

NCSCRIIGYHLTLU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00321076

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

18.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.900

Distribution Coefficient, logD

3.900

Water Solubility, LogSw

-4.00

Polar Surface Area

102.169

Acid Dissociation Constant (pKa)

12.47

Base Dissociation Constant (pKb)

-0.27

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

58.30

6623-2029 in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with 6623-2029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6623-2029?
Check Price and Availability of 6623-2029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6623-2029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6623-2029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6623-2029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6623-2029 available by request